Brainstorm Cell Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $683 | 2.5k | 0.27 |
| 2023-09-30 | $728 | 3.6k | 0.20 |
| 2023-06-30 | $5.2k | 2.5k | 2.06 |
| 2023-03-31 | $25k | 7.5k | 3.30 |
| 2022-12-31 | $12k | 7.5k | 1.64 |
| 2022-09-30 | $33k | 7.5k | 4.40 |
| 2022-06-30 | $22k | 7.8k | 2.80 |
| 2022-03-31 | $37k | 7.7k | 4.85 |
| 2021-12-31 | $58k | 14k | 4.00 |
| 2021-09-30 | $37k | 11k | 3.33 |
| 2021-06-30 | $54k | 14k | 3.84 |
| 2021-03-31 | $63k | 16k | 3.86 |
| 2020-12-31 | $50k | 11k | 4.45 |
| 2020-09-30 | $144k | 8.5k | 16.94 |
| 2020-06-30 | $189k | 17k | 11.18 |
| 2020-03-31 | $12k | 2.5k | 4.80 |
| 2019-12-31 | $11k | 2.5k | 4.40 |
| 2019-09-30 | $10k | 2.5k | 4.00 |
| 2019-06-30 | $20k | 5.1k | 4.00 |
| 2018-12-31 | $7.0k | 2.0k | 3.58 |
| 2018-09-30 | $2.0k | 521 | 3.84 |
| 2018-03-31 | $5.6k | 1.6k | 3.63 |
| 2017-12-31 | $7.0k | 1.9k | 3.68 |
| 2017-09-30 | $17k | 4.1k | 4.18 |
| 2017-06-30 | $8.4k | 2.2k | 3.81 |
| 2017-03-31 | $25k | 5.8k | 4.27 |
| 2016-12-31 | $2.0k | 900 | 2.22 |
| 2016-06-30 | $13k | 5.4k | 2.41 |
| 2015-12-31 | $3.0k | 1.0k | 2.95 |
| 2015-09-30 | $2.0k | 1.0k | 1.97 |
| 2015-03-31 | $21k | 4.2k | 4.92 |